A detailed history of Baker Chad R transactions in Danaher Corp stock. As of the latest transaction made, Baker Chad R holds 64,220 shares of DHR stock, worth $17.1 Million. This represents 3.41% of its overall portfolio holdings.

Number of Shares
64,220
Previous 64,245 0.04%
Holding current value
$17.1 Million
Previous $16 Million 0.01%
% of portfolio
3.41%
Previous 3.46%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$235.51 - $267.98 $5,887 - $6,699
-25 Reduced 0.04%
64,220 $16 Million
Q1 2024

Apr 17, 2024

SELL
$224.58 - $256.19 $3,368 - $3,842
-15 Reduced 0.02%
64,245 $16 Million
Q4 2023

Jan 22, 2024

SELL
$185.1 - $233.13 $5,553 - $6,993
-30 Reduced 0.05%
64,260 $14.9 Million
Q3 2023

Oct 17, 2023

BUY
$233.08 - $265.59 $86,239 - $98,268
370 Added 0.58%
64,290 $16 Million
Q2 2023

Jul 18, 2023

BUY
$224.99 - $256.14 $40,498 - $46,105
180 Added 0.28%
63,920 $15.3 Million
Q1 2023

Apr 27, 2023

BUY
$239.75 - $277.0 $296,091 - $342,095
1,235 Added 1.98%
63,740 $16.1 Million
Q4 2022

Feb 10, 2023

SELL
$241.42 - $282.29 $43,455 - $50,812
-180 Reduced 0.29%
62,505 $16.6 Million
Q3 2022

Nov 03, 2022

SELL
$247.06 - $1507.4 $4,941 - $30,148
-20 Reduced 0.03%
62,685 $16.2 Million
Q1 2022

May 10, 2022

SELL
$257.27 - $315.76 $9,004 - $11,051
-35 Reduced 0.06%
62,705 $18.4 Million
Q1 2021

May 11, 2021

SELL
$212.38 - $245.9 $8,495 - $9,836
-40 Reduced 0.06%
62,740 $14.1 Million
Q4 2019

Feb 12, 2020

SELL
$133.47 - $153.48 $10,010 - $11,511
-75 Reduced 0.12%
62,780 $9.64 Million
Q4 2017

Feb 13, 2018

BUY
$85.26 - $94.62 $149,205 - $165,585
1,750 Added 2.86%
62,855 $5.83 Million
Q2 2017

Aug 14, 2017

BUY
N/A
61,105
61,105 $5.16 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $194B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Baker Chad R Portfolio

Follow Baker Chad R and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

News

Stay updated on Baker Chad R with notifications on news.